However, Ppara-null mice are resistant to PPARα agonists-induced liver cancer demonstrating that PPARα mediates hepatocarcinogenesis resulting from exposure to these non-genotoxic rodent carcinogens [13,14,15,16,17]. The gene discussed is PPARA; the disease is liver cancer.